merislon eisai tokyo japan 相關
廣告HomeToGo®: Easy Multi-Site Price Comparison. Search and Save Up to 75% Now! Best Tokyo Vacation Rentals from Your Favourite Sites. Find Your Dream Vacation Home Now!
搜尋結果
2024年3月29日 · March 29, 2024. Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon ® (generic name: betahistine mesilate) and muscle relaxant Myonal ® (generic name: eperisone hydrochloride) in Japan to Kaken ...
2024年3月29日 · TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon® (generic name: betahistine mesilate) and muscle relaxant Myonal® (generic name: eperisone hydrochloride) in Japan to Kaken Pharmaceutical Co., Ltd.
2024年3月30日 · Mar 30, 2024 | Business. Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon® (generic name: betahistine mesilate) and muscle relaxant Myonal® (generic name: eperisone hydrochloride) in Japan to Kaken Pharmaceutical Co., Ltd.
2024年3月29日 · image credit- shutterstock. Eisai Co. has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon (generic name: betahistine mesilate) and muscle relaxant Myonal (generic name: eperisone hydrochloride) in Japan to Kaken Pharmaceutical.
2024年3月29日 · TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon (generic name: betahistine mesilate) and muscle relaxant Myonal (generic name: eperisone hydrochloride) in Japan to Kaken Pharmaceutical Co., Ltd.
2024年4月2日 · Eisai has signed an agreement for the divestiture of rights for Merislon and Myonal, two of its long-standing products in Japan, to Kaken Pharmaceutical. The transaction is valued at Y3.8bn ($25.10m).
2024年3月29日 · Eisai today announced that it has entered into an agreement to divest its Japanese rights for vertigo and equilibrium disturbance treatment Merislon (betahistine mesilate) and muscle relaxant Myonal (eperisone hydrochloride) to fellow Japan based Kaken Pharmaceutical.
![Jual Eisai Merislon 12 mg Obat [10 Tablet] di Seller Arena medika - Pal ...](https://hk.images.search.yahoo.com/search/images?p=merislon+eisai+tokyo+japan&ei=UTF-8&fl=0&rd=r2&_tsrc=yahoo&_lang=zh-hant-tw&_sep=fp&_intl=hk&age=1m&th=109.7&tw=109.7&imgurl=https%3A%2F%2Fwww.static-src.com%2Fwcsstore%2FIndraprastha%2Fimages%2Fcatalog%2Ffull%2F93%2FMTA-12680255%2Feisai_merislon-12-mg-10-tablet_full02.jpg&rurl=https%3A%2F%2Fwww.blibli.com%2Fp%2Feisai-merislon-12-mg-obat-10-tablet%2Fps--ARM-70006-00400&size=53KB&name=Jual+Eisai+Merislon+12+mg+Obat+%5B10+Tablet%5D+di+Seller+Arena+medika+-+Pal+...&oid=2&h=800&w=800&turl=https%3A%2F%2Ftse1.mm.bing.net%2Fth%3Fid%3DOIP.bDtKVjTlbfTZRi0enn4XDQHaHa%26pid%3DApi%26rs%3D1%26c%3D1%26qlt%3D95%26w%3D109%26h%3D109&tt=Jual+Eisai+Merislon+12+mg+Obat+%5B10+Tablet%5D+di+Seller+Arena+medika+-+Pal+...&sigr=s7h.mU6r3Xxd&sigit=NP5Dlsz5ld.H&sigi=wbN7N7T2J3kB&sign=x6lCFTGcY19O&sigt=x6lCFTGcY19O "Jual Eisai Merislon 12 mg Obat [10 Tablet] di Seller Arena medika - Pal ...")
